Collective Family Office’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-256
| Closed | -$225K | – | 182 |
|
|
2023
Q4 | $225K | Sell |
256
-99
| -28% | -$87K | 0.08% | 157 |
|
|
2023
Q3 | $292K | Buy |
355
+50
| +16% | +$41.1K | 0.11% | 135 |
|
|
2023
Q2 | $219K | Buy |
+305
| New | +$219K | 0.09% | 164 |
|
|
2022
Q3 | – | Sell |
-476
| Closed | -$281K | – | 194 |
|
|
2022
Q2 | $281K | Buy |
476
+172
| +57% | +$102K | 0.12% | 154 |
|
|
2022
Q1 | $212K | Sell |
304
-155
| -34% | -$108K | 0.08% | 182 |
|
|
2021
Q4 | $290K | Sell |
459
-19
| -4% | -$12K | 0.11% | 153 |
|
|
2021
Q3 | $289K | Sell |
478
-3
| -0.6% | -$1.81K | 0.12% | 141 |
|
|
2021
Q2 | $269K | Sell |
481
-75
| -13% | -$41.9K | 0.12% | 147 |
|
|
2021
Q1 | $263K | Buy |
+556
| New | +$263K | 0.13% | 144 |
|